Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment

Journal of the American Academy of Dermatology

Volumn 55, Issue 5 SUPPL., 2006, Pages

  Peramiquel, Laura ^a   Dalmau, Joan ^a   Puig, Luís ^a   Roé, Esther ^a   Fernández Figueras, M Teresa ^b   Alomar, Agustín ^a  

^a Hosp de la Santa Creu I Sant Pau   (Spain)

^b Hospital Germans   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CORTICOSTEROID;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; COLON ADENOCARCINOMA; DRUG INDUCED DISEASE; DYSESTHESIA; EDEMA; ERYTHEMA; HAND FOOT SYNDROME; HUMAN; HUMAN TISSUE; KERATOSIS; MALE; PAPULE; PRIORITY JOURNAL; PUNCH BIOPSY; RASH;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DEOXYCYTIDINE; ERYTHEMA; FLUOROURACIL; HUMANS; KERATOSIS; MALE; PARESTHESIA;

EID: 33750063684     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.11.1100     Document Type: Article

References (5)

1. Lewis K.G., Lewis M.D., Robinson-Bostom L., and Pan T.D. Inflammation of actinic keratoses during capecitabine therapy. Arch Dermatol 140 (2004) 367-368
2. Walko C.M., and Lindley C. Capecitabine: a review. Clin Ther 27 (2005) 23-44
3. Malet-Martino M., and Martino R. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist 7 (2002) 288-323
4. Falkson G., and Schulz E. Skin changes in patients treated with 5-fluorouracil. Br J Dermatol 74 (1962) 229-236
5. Remlinger K.A. Cutaneous reactions to chemotherapy drugs: the art of consultation. Arch Dermatol 139 (2003) 77-81